以三叉为灵感的基于富可伊丹的穿甲微囊用于编程急性肺栓塞治疗
Ning Yang1, Weikun Li1, Zhicheng Qian2
1School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, PR China.
Colloids and surfaces. B, Biointerfaces
|October 23, 2024
概括
一个新的微囊 (FUGP@MC) 为急性肺栓塞 (APE) 提供了有针对性的三重作用疗法. 这种方法结合了光热,机械和药理方法,显示出比传统治疗方法更好的疗效和安全性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺栓塞 (PE) 是导致死亡的主要原因,当前的血栓溶解疗法面临着短半衰期和出血风险等局限性.
- 现有的急性肺栓塞 (APE) 治疗方法需要改进向和疗效.
- 开发先进的药物输送系统对于有效的PE治疗至关重要.
研究的目的:
- 开发一种新型的微囊 (FUGP@MC),用于在急性肺栓塞 (APE) 中增强血栓溶解.
- 研究光热,机械和药理性血栓溶解的协同效应.
- 评估FUGP@MC系统的体内安全性和有效性.
主要方法:
- 用于针对性APE治疗的fucoidan-urokinase-S-nitrosoglutathione-polydopamine微囊 (FUGP@MC) 的制造.
- 利用近红外 (NIR) 光触发光热转换,氧化 (NO) 释放和尿素酶 (UK) 激活的级联.
- 通过测量栓塞残留率来评估血栓溶解疗效,并评估体内生物安全性.
主要成果:
- 在FUGP@MC中,与单独的尿素激酶 (16.78%) 相比,在较低的英国剂量下,栓残留率显著降低 (6.35%).
- 微囊系统通过光热,机械 (NO介导) 和药理作用的结合,实现了三重协同的血栓缓解作用.
- FUGP@MC在体内表现出可靠的生物安全性,表明了有利的安全性.
结论:
- 以三叉为灵感的FUGP@MC系统为急性肺栓塞提供了一个有前途的多模式治疗策略.
- 这种新的方法提供了一种潜在的更安全,更有效的替代方案,而不是当前的血栓溶解药物输送方法.
- FUGP@MC展示了先进纳米技术在克服传统PE治疗的局限性的潜力.
相关概念视频
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
1
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
1
01:27Pulmonary Embolism III: Nursing Management
1
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
1
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
154
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
154